PLEASANTON, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in products to treat cardiovascular disease, today announced the appointment of healthcare executive Steven H. Collis to its board of directors, effective January 1, 2008. His appointment brings the Thoratec board to nine directors.
Collis, who will join the board's compensation and option committee, is executive vice president of AmerisourceBergen Corporation, and president of its Dallas-based AmerisourceBergen Specialty Group (ABSG). ABSG delivers specialty pharmaceuticals and related services to physician offices, including reimbursement consulting and physician education.
Collis joined AmerisourceBergen in 1994 as a general manager in ASD Specialty Healthcare, and was named president of its Specialty Group in 1999. He was previously a principal and general manager of Sterling Medical, a national provider and distributor of medical disposable supplies, health management services and continuous quality management programs to the home care market.
Born and educated in South Africa, Collis holds a Bachelor of Commerce with Honors degree from the University of the Witwatersrand in Johannesburg. He received his Charter Accountancy license, the South African equivalent of a Certified Public Accountant license.
"We are very excited to have someone with Steve's extensive and
impressive operational expertise join our board. Steve's experience
shepherding ABSG through extensive growth provides him with insight that
will be of great value to Thoratec," said Gary F. Burbach, president and
chief executive officer of Thoratec. "We are certain Steve will make a
meaningful contribution to the board and
|SOURCE Thoratec Corporation|
Copyright©2007 PR Newswire.
All rights reserved